Huminsulin Normal Patronen Lilly

Huminsulin Normal Patronen Lilly is a cartridge (patron) formulation of insulin human produced by recombinant DNA technology. It contains the active ingredient insulin human (rDNA) and is supplied in a cartridge for subcutaneous injection. The product is marketed in the European Union and is available by prescription for the management of diabetes mellitus in both type 1 and type 2 patients as a rapid‑acting insulin analogue that mimics physiological insulin secretion.

Huminsulin Normal Patronen Lilly is indicated for the control of blood glucose in patients with diabetes mellitus.

- Type 1 diabetes mellitus - Type 2 diabetes mellitus when other therapies are insufficient - Adjunct to diet and exercise for glycemic management - Use in multiple daily injection or insulin‑pump regimens - May be considered during pregnancy under close medical supervision

Like other insulin preparations, Huminsulin Normal Patronen Lilly may be associated with adverse reactions, which can be classified by frequency.

Common: - Hypoglycemia (low blood glucose) - Redness, swelling, or pain at the injection site - Lipodystrophy or lipoatrophy at repeated injection sites - Weight gain - Mild allergic skin rash

Serious: - Severe hypoglycemia leading to loss of consciousness - Anaphylactic reaction or angioedema - Hypokalemia (low potassium levels) - Significant edema or fluid retention - Development of insulin resistance requiring dose escalation

Patients and healthcare providers should consider several safety points when using Huminsulin Normal Patronen Lilly.

- Regular self‑monitoring of blood glucose to detect hypoglycemia early - Adjust doses in renal or hepatic impairment, as insulin clearance may be reduced - Use with caution during pregnancy and lactation; consult a specialist - Store cartridges refrigerated and protect from light; discard after the indicated in‑use period - Do not use if there is a known hypersensitivity to human insulin or any excipients - Educate patients on recognizing and managing hypoglycemia symptoms

Huminsulin Normal Patronen Lilly can interact with other medicines, influencing glucose control or insulin action.

Avoid: - Concurrent use of sulfonylureas or meglitinides, which may potentiate hypoglycemia - High‑dose thiazide diuretics that can raise blood glucose levels - Systemic corticosteroids that increase insulin resistance

Use with caution: - Non‑selective beta‑blockers, which may mask hypoglycemia signs - ACE inhibitors or ARBs, as they can enhance insulin sensitivity and affect potassium - Alcohol consumption, which can cause unpredictable glucose fluctuations - Intensive physical exercise, requiring possible dose adjustments